patientportal.aegislabs.com – In support of the Coronavirus testing efforts, healthcare facilities, retail clinics, and urgent care centers rely heavily on the patient portal to issue COVID-19 test results. Organizations and technology companies alike are under pressure to make sure patient portals are accessible, usable, and that patients can understand lab info they view on the portal.
In the Aegis system, the TAT is calculated from the time samples are logged into the laboratory tracking system to the time test reports are returned. The transit time to the lab is not included in the calculation. Aegis makes use of overnight shipping after collection with all of its collection partners. The length of time between the collection event and the final Aegis report may be affected by shipping delays and weekend shipping schedules.
You can keep up to date with the latest updates by logging in to patientportal.aegislabs.com.
The portal will display that the sample has been received in the laboratory and the testing has begun when the sample has been received and the testing has begun. Once the testing has been completed, results will appear in the portal. Your results will also be sent to you via email as soon as they are released.
As a result of the transmission of SARS-CoV-2, millions of individuals have been sickened around the world in the past year. Even in spite of the fact that knowledge about the virus causing COVID-19 has grown significantly, healthcare providers, epidemiologists, virologists, and laboratory scientists have faced a significant uphill battle in containing COVID-19’s spread and treating the patients who are infected.
The SARS-CoV-2 virus has undergone mutation over the last few months, like many other respiratory pathogens, potentially contributing to the increase in infectiousness and illness. Due to their apparent increased transmissibility, genetic variants of the COVID-19 virus including B.1.1.7 and 501Y.V2 have attracted the attention of the public and those assisting in treatment. Furthermore, concerns have been raised regarding the ability of commonly used testing methods to identify these new genetic variants.
Thermo Fisher Scientific TaqPathTM COVID-19 Combo Kit is used by Aegis Sciences Corporation for COVID-19 diagnostic testing. Three genetic targets of SARS-CoV-2 are analyzed by this highly sensitive and specific testing method. Current COVID variants (i.e. B.1.17) will not affect the sensitivity, or risk for false negatives, of TaqPathTM COVID-19 Combo Kit. Additionally, recent findings that demonstrate the TaqPath kit is not prone to false-negative results when used with individuals infected with COVID variants are also supporting the FDA’s viewpoint.1,2 It is possible that other testing methodologies that do not use 3 genes in testing may also be impacted by these variant strains.
In performing over 3 million diagnostic tests to date, Aegis Sciences Corporation has continued to provide healthcare providers with highly sensitive and specific diagnostic test results within a clinically relevant turnaround time. Through the Pandemic, our clinical and laboratory scientists will continue to monitor the scientific literature and clinical guidelines for testing based on the ongoing changes. With rapid, accurate, and technically superior performance, our mission is to help clinicians make better decisions.
patientportal.aegislabs.com: Reports Easy-To-Understand Test Results
It has been shown that patients prefer to receive their lab results via an email message or the patient portal regardless of the outcome.
Approximately three-fourths of those surveyed reported spending as much as an hour awaiting test results at a physician’s office or hospital, suggesting such processes may be time-consuming. In addition, 31 percent of respondents said receiving lab results, such as a COVID-19 test, reduces the chance of missing important clinical information. The results are stored in the portal, so they can refer to them easily when needed.
patientportal.aegislabs.com: Clearly explains instructions
Despite the fact that many healthcare organizations have offered patient portal access for quite some time, the technology has only become widely used following the COVID-19 pandemic. Nearly every hospital offers access to its patient portal, according to the ONC, but only about a quarter of patients use it.
Even though there are no concrete data for the COVID-19 pandemic, anecdotal evidence indicates its importance. Many patients recognize the utility of a portal account in their healthcare journey, so they are registering for one. This is in part due to the patient portal’s ability to provide COVID-19 lab results.
Maintaining An Organized Call Center
The patient can still pick up the phone when viewing her COVID-19 lab test results through the patient portal. It is possible that she does not understand her results or that she may wish to follow up about the next steps, even if she has tested negative.
The patient portal may not be accessible for some patients, and they may want to access results via the clinic or hospital call center. The patient experience will be positively impacted if those lines remain open and move quickly.